In response to reports on the procedures followed for the referral of patients to the private sector and the approval of medicines by the Pharmaceutical Services Nominating Committee, the Ministry of Health clarifies the following:
- The Ministry of Health, in proposals submitted to the Ministry of Finance for the 2023 budget, included provisions of 18 million 18 million for subsidised patients in the private sector in Cyprus, 25 million for patient missions abroad and 80 million for medicines approved by the Nominal Claims Committee (NCC). These amounts are an estimate based on actual expenditure in previous years for budgeting purposes.
- The Ministry of Health, in five letters to the President of the Health Insurance Agency, attached lists of medicines for which claims had been submitted to the Nominal Claims Committee and repeatedly requested the evaluation of these medicines for inclusion in the lists reimbursed by the Health Insurance Agency.
- The Names Claims Committee (NCC) is responsible for reviewing names claims for the administration of drugs that are not on the list of drugs reimbursed by the Health Insurance Agency or that are on that list and are outside the terms and conditions set by the HHA. In accordance with the established procedure, the doctor applies for the administration of the above-mentioned medicines to the EDA committee, which is composed of four doctors and three pharmacists, and each request is examined individually.
- It should be noted that, at present, new innovative medicines and new revised pharmacotherapies covering the whole range of conditions such as cancer, haematological, neurological, neurological, pulmonary, psychiatric, rheumatological, antimicrobial, gene therapy, chronic and/or rare diseases, etc. are provided to Cypriot citizens only through the approval of requests by the EOA.
- It is stressed that in the years 2016-2020 the approvals of the EIOs concerned only requests from doctors of the public hospitals, the Oncology Department of the Bank of Cyprus and the Institute of Neurology and Genetics for the eligible patients of the previous system (before the implementation of the GHS about 600 thousand beneficiaries).
- From 2021 onwards, EOA's approvals concern requests from all physicians contracted to the General Health Insurance Scheme (OKYPY, private hospitals, clinics, Bank of Cyprus Oncology, Institute of Neurology and Genetics, German Oncology Centre, Mediteranean Hospital etc.) for all eligible patients of the General Health Insurance Scheme (about 950 thousand beneficiaries).
- The expenditure of the EMA does not only concern the initiation of pharmacotherapies but also their continuation. That is, if a patient's continuation of treatment for the following years is approved by the EMA, it is still covered by an EMA allocation. Therefore, as more patients are approved each year, the amount of this budget increases.
The Ministry of Health, after the implementation of the second phase of the GHS and in consultation with the OAI, refers patients to the private sector in Cyprus for services that cannot currently be handled under the GHS. In this regard, there is a relevant letter from An.
- All referrals, without exception, are made on the basis of statutory procedures and a positive opinion of the Specialist Medical Committees in accordance with the provisions of the Financial Assistance Plan, which is followed by the Ministry of Health.
- All referrals are made on the basis of statutory procedures and a positive opinion of the Specialist Medical Committees in accordance with the provisions of the Financial Assistance Plan, which is followed by the Ministry of Health.
- All referrals are handled by the Ministry of Health, either abroad or at home, in order to safeguard public health and avoid endangering human lives, and concern categories of health services that have not yet been able to be included in the GHS. Referrals abroad concern complex and difficult cases which require a multidisciplinary team and/or specialised expertise and cannot be treated on the territory of the Republic of Cyprus.
It is emphasised that all procedures are subject to an annual audit by the Audit Service.
The Ministry of Health is committed to patient care and unhindered access to health services. Issues of health and human life do not lend themselves to frivolous judgments and petty political considerations.
(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO
Source